P3 Health Partners Inc. Net Income (Loss) Available to Common Stockholders, Diluted
P3 Health Partners Inc. (PIII) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$9.20 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2023-05-10
- P3 Health Partners Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2023-03-31 was -$9.20M.
- P3 Health Partners Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-12-31 was $759.10M.
- P3 Health Partners Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-09-30 was -$65.33M.
- P3 Health Partners Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2022-06-30 was -$903.11M.
- P3 Health Partners Inc. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$270.13M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 1 month | Net Income (Loss) Available to Common Stockholders, Diluted 1 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2023-03-31 | -$9.20M 10-Q · filed 2023-05-10 | $749.90M derived: sum of 2 quarters · filed 2023-05-10 | $684.57M derived: sum of 3 quarters · filed 2023-05-10 | -$218.54M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2022-12-31 | $759.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $693.77M derived: sum of 2 quarters · filed 2023-03-31 | -$209.34M derived: sum of 3 quarters · filed 2023-03-31 | -$270.13M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$65.33M 10-Q · filed 2022-11-14 | -$968.43M derived: sum of 2 quarters · filed 2022-11-14 | -$1.03B 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$903.11M 10-Q · filed 2022-10-21 | -$963.90M 10-Q · filed 2022-10-21 | |||||
| 2022-03-31 | -$10.58M 10-Q · filed 2023-05-10 | -$10.58M 10-Q · filed 2022-10-21 | |||||
| 2021-12-31 | -$10.08M 10-K · filed 2023-03-31 | -$10.08M 10-K · filed 2022-10-21 |